Browse
Submit Data
Databases
API
Help

Dataset Information

22 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Author Correction: Activation of endothelial ?-catenin signaling induces heart failure.

ABSTRACT: A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

SUBMITTER: Nakagawa A

PROVIDER: S-EPMC6206138 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Author Correction: Activation of endothelial β-catenin signaling induces heart failure.

Nakagawa Akito A Naito Atsuhiko T AT Sumida Tomokazu T Nomura Seitaro S Shibamoto Masato M Higo Tomoaki T Okada Katsuki K Sakai Taku T Hashimoto Akihito A Kuramoto Yuki Y Oka Toru T Lee Jong-Kook JK Harada Mutsuo M Ueda Kazutaka K Shiojima Ichiro I Limbourg Florian P FP Adams Ralf H RH Noda Tetsuo T Sakata Yasushi Y Akazawa Hiroshi H Komuro Issei I

Scientific reports 20181029 1

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper. ...[more]

PMID: 30374020

Similar Datasets

Activation of endothelial ?-catenin signaling induces heart failure.

Project description:Activation of ?-catenin-dependent canonical Wnt signaling in endothelial cells plays a key role in angiogenesis during development and ischemic diseases, however, other roles of Wnt/?-catenin signaling in endothelial cells remain poorly understood. Here, we report that sustained activation of ?-catenin signaling in endothelial cells causes cardiac dysfunction through suppressing neuregulin-ErbB pathway in the heart. Conditional gain-of-function mutation of ?-catenin, which activates Wnt/?-catenin signaling in Bmx-positive arterial endothelial cells (Bmx/CA mice) led to progressive cardiac dysfunction and 100% mortality at 40 weeks after tamoxifen treatment. Electron microscopic analysis revealed dilatation of T-tubules and degeneration of mitochondria in cardiomyocytes of Bmx/CA mice, which are similar to the changes observed in mice with decreased neuregulin-ErbB signaling. Endothelial expression of Nrg1 and cardiac ErbB signaling were suppressed in Bmx/CA mice. The cardiac dysfunction of Bmx/CA mice was ameliorated by administration of recombinant neuregulin protein. These results collectively suggest that sustained activation of Wnt/?-catenin signaling in endothelial cells might be a cause of heart failure through suppressing neuregulin-ErbB signaling, and that the Wnt/?-catenin/NRG axis in cardiac endothelial cells might become a therapeutic target for heart failure.

| S-EPMC4857119 | biostudies-literature

Author Correction: A potential role for somatostatin signaling in regulating retinal neurogenesis.

Project description: Not available

| S-EPMC8368217 | biostudies-literature

Author Correction: CRISPR-based transcriptional activation tool for silent genes in filamentous fungi.

Project description: Not available

| S-EPMC8492761 | biostudies-literature

Author Correction: Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice.

Project description: Not available

| S-EPMC7966759 | biostudies-literature

Activation of Wnt/?-catenin protein signaling induces mitochondria-mediated apoptosis in hematopoietic progenitor cells.

Project description:The canonical Wnt/?-catenin signaling is activated during development, tumorigenesis, and in adult homeostasis, yet its role in maintenance of hematopoietic stem/progenitor cells is not firmly established. Here, we demonstrate that conditional expression of an active form of ?-catenin in vivo induces a marked increase in the frequency of apoptosis in hematopoietic stem/progenitor cells (HSCs/HPCs). Activation of Wnt/?-catenin signaling in HPCs in vitro elevates the activity of caspases 3 and 9 and leads to a loss of mitochondrial membrane potential (??(m)), indicating that it induces the intrinsic mitochondrial apoptotic pathway. In vivo, expression of activated ?-catenin in HPCs is associated with down-regulation of Bcl2 and expression of Casp3. Bone marrow transplantation assays reveal that enhanced cell survival by a Bcl2 transgene re-establishes the reconstitution capacity of HSCs/HPCs that express activated ?-catenin. In addition, a Bcl2 transgene prevents exhaustion of these HSCs/HPCs in vivo. Our data suggest that activation of the Wnt/?-catenin pathway contributes to the defective function of HPCs in part by deregulating their survival.

| S-EPMC3391123 | biostudies-literature

Author Correction: Smoking induces DNA methylation changes in Multiple Sclerosis patients with exposure-response relationship.

Project description:A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

| S-EPMC5841427 | biostudies-literature

Correction: Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.

Project description:[This corrects the article DOI: 10.1371/journal.pone.0098047.].

| S-EPMC6675059 | biostudies-literature

Transcription Factor 7-like 2 Mediates Canonical Wnt/?-Catenin Signaling and c-Myc Upregulation in Heart Failure.

Project description:How canonical Wnt/?-catenin signals in adult hearts, especially in different diseased states, remains unclear. The proto-oncogene, c-Myc, is a Wnt target and an early response gene during cardiac stress. It is not clear whether c-Myc is activated or how it is regulated during heart failure.We investigated canonical Wnt/?-catenin signaling and how it regulated c-Myc expression in failing hearts of human ischemic heart disease, idiopathic dilated cardiomyopathy, and murine desmin-related cardiomyopathy. Our data demonstrated that canonical Wnt/?-catenin signaling was activated through nuclear accumulation of ?-catenin in idiopathic dilated cardiomyopathy, ischemic heart disease, and murine desmin-related cardiomyopathy when compared with nonfailing controls and transcription factor 7-like 2 (TCF7L2) was the main ?-catenin partner of the T-cell factor (TCF) family in adult hearts. We further revealed that c-Myc mRNA and protein levels were significantly elevated in failing hearts by real-time reverse transcription polymerase chain reaction, Western blotting, and immunohistochemical staining. Immunoprecipitation and confocal microscopy further showed that ?-catenin interacted and colocalized with TCF7L2. More importantly, chromatin immunoprecipitation confirmed that ?-catenin and TCF7L2 were recruited to the regulatory elements of c-Myc. This recruitment was associated with increased histone H3 acetylation and transcriptional upregulation of c-Myc. With lentiviral infection, TCF7L2 overexpression increased c-Myc expression and cardiomyocyte size, whereas shRNA-mediated knockdown of TCF7L2 suppressed c-Myc expression and cardiomyocyte growth in cultured neonatal rat cardiomyocytes.This study indicates that TCF7L2 mediates canonic Wnt/?-catenin signaling and c-Myc upregulation during abnormal cardiac remodeling in heart failure and suppression of Wnt/?-catenin to c-Myc axis can be explored for preventing and treating heart failure.

| S-EPMC5060009 | biostudies-literature

Contribution of central nervous system endothelial nitric oxide synthase to neurohumoral activation in heart failure rats.

Project description:Neurohumoral activation, a hallmark in heart failure (HF), is linked to the progression and mortality of HF patients. Thus, elucidating its precise underlying mechanisms is of critical importance. Other than its classic peripheral vasodilatory actions, the gas NO is a pivotal neurotransmitter in the central nervous system control of the circulation. While accumulating evidence supports a contribution of blunted NO function to neurohumoral activation in HF, the precise cellular sources, and NO synthase (NOS) isoforms involved, remain unknown. Here, we used a multidisciplinary approach to study the expression, cellular distribution, and functional relevance of the endothelial NOS isoform within the hypothalamic paraventricular nucleus in sham and HF rats. Our results show high expression of endothelial NOS in the paraventricular nucleus (mostly confined to astroglial cells), which contributes to constitutive NO bioavailability, as well as tonic inhibition of presympathetic neuronal activity and sympathoexcitatory outflow from the paraventricular nucleus. A diminished endothelial NOS expression and endothelial NOS-derived NO availability were found in the paraventricular nucleus of HF rats, resulting, in turn, in blunted NO inhibitory actions on neuronal activity and sympathoexcitatory outflow. Taken together, our study supports blunted central nervous system endothelial NOS-derived NO as a pathophysiological mechanism underlying neurohumoral activation in HF.

| S-EPMC3189581 | biostudies-literature

Author Correction: Diffraction-limited ultrabroadband terahertz spectroscopy.

Project description:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

| S-EPMC7170850 | biostudies-literature